[Autoimmune hepatitis in children].

Area of Science:

• Pediatric gastroenterology and hepatology
• Autoimmune liver diseases
• Immunomodulatory therapy

Context:

• Autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are rare autoimmune liver conditions.
• Overlap syndrome, a combination of AIH and PSC, also occurs in children.
• Early diagnosis and treatment are vital to prevent liver failure.

Purpose:

• To review the clinical characteristics, treatment, and outcomes of children diagnosed with AIH, PSC, or overlap syndrome.
• To evaluate the efficacy of immunomodulatory therapy in this pediatric population.
• To highlight the importance of timely diagnosis in managing autoimmune liver diseases in children.

Summary:

• A retrospective study identified 18 children with autoimmune liver disease (11 AIH, 6 PSC, 1 overlap).
• Four PSC patients and the overlap patient had inflammatory bowel disease (ulcerative colitis or Crohn's disease).
• Most children responded well to prednisolone and azathioprine, with no patients requiring a liver transplant.

Impact:

• Immunomodulatory therapy demonstrates significant efficacy in treating pediatric autoimmune liver diseases.
• Prompt diagnosis and treatment can lead to favorable outcomes and prevent the need for liver transplantation.
• This study underscores the importance of recognizing and managing these rare conditions in children.